{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:15:08Z","timestamp":1794392108272,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijantimicag.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:09:20Z","timestamp":1537150160000},"page":"842-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"title":["Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus"],"prefix":"10.1016","volume":"52","author":[{"given":"Tamta","family":"Tkhilaishvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Brit","family":"Klatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Trampuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-034X","authenticated-orcid":false,"given":"Mariagrazia","family":"Di Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0001","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tim.2011.06.004","article-title":"Staphylococcal biofilm disassembly","volume":"19","author":"Boles","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3201\/eid0809.020063","article-title":"Biofilms: microbial life on surfaces","volume":"8","author":"Donlan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0005","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nmicrobiol.2016.51","article-title":"Persister formation in Staphylococcus aureus is associated with ATP depletion","volume":"1","author":"Conlon","year":"2016","journal-title":"Nature Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1078\/1438-4221-00196","article-title":"Mechanisms of antibiotic resistance in bacterial biofilms","volume":"292","author":"Stewart","year":"2002","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0007","doi-asserted-by":"crossref","unstructured":"Di Luca M, Navari E, Esin S, Menichini M, Barnini S, Trampuz A, et al. Detection of biofilms in biopsies from chronic rhinosinusitis patients: in vitro biofilm forming ability and antimicrobial susceptibility testing in biofilm mode of growth of isolated bacteria. Advances in Experimental Medicine and Biology. Boston, MA: Springer US; 2017. p. 1-28.","DOI":"10.1007\/5584_2017_34"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary Rationale for Phages as Complements of Antibiotics","volume":"24","author":"Torres-Barcelo","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.resmic.2018.05.010","article-title":"Real-time assessment of bacteriophage T3-derived antimicrobial activity against planktonic and biofilm-embedded Escherichia coli by isothermal microcalorimetry","author":"Tkhilaishvili","year":"2018","journal-title":"Res Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0011","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens","volume":"4","author":"Kvachadze","year":"2011","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0012","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0014","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fmicb.2018.00127","article-title":"Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms","volume":"9","author":"Kumaran","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0015","series-title":"Bacteriophages","first-page":"27","article-title":"Enumeration of bacteriophage particles.","author":"Adams","year":"1959"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0016","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/08927014.2011.631169","article-title":"Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin","volume":"27","author":"Rahman","year":"2011","journal-title":"Biofouling"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0017","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1128\/AEM.01789-14","article-title":"Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation","volume":"80","author":"Alves","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0018","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/jac\/dkx265","article-title":"Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis","volume":"72","author":"Gonzalez Moreno","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0019","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/AAC.02583-12","article-title":"Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model","volume":"58","author":"Oliva","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/08927014.2014.888062","article-title":"Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis","volume":"30","author":"Brancatisano","year":"2014","journal-title":"Biofouling"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0021","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3389\/fmicb.2017.01917","article-title":"Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical treatment and evaluation of their susceptibility to membrane-targeting agents","volume":"8","author":"Grassi","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0022","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cid\/ciw200","article-title":"Beyond antibiotics: new therapeutic approaches for bacterial infections","volume":"63","author":"Hauser","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0024","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antibiotics3030270","article-title":"Bacteriophages and biofilms","volume":"3","author":"Harper","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mib.2017.09.004","article-title":"Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections","volume":"39","author":"Pires","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0026","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2106\/JBJS.K.01135","article-title":"Bacteriophage therapy in implant-related infections: an experimental study","volume":"95","author":"Yilmaz","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0027","series-title":"Phage Therapy: Current Research and Applications Norfolk","article-title":"The use of bacteriophages and bacteriophage-derived enzymes for clinically relevant biofilm control","author":"Sillankorva","year":"2014"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0028","series-title":"Bacteriophages and biofilms: Ecology, phage therapy, plaques","author":"Abedon","year":"2011"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnv246","article-title":"Bacteriophage exploitation of bacterial biofilms: phage preference for less mature targets?","volume":"363","author":"Abedon","year":"2016","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0030","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/infdis\/jit637","article-title":"Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus\u2013induced murine bacteremia","volume":"209","author":"Schuch","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0031","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijantimicag.2013.06.020","article-title":"Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia","volume":"42","author":"Vouillamoz","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0032","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1586\/14787210.2015.1100533","article-title":"Prevention and treatment of Staphylococcus aureus biofilms","volume":"13","author":"Bhattacharya","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0033","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.qco.0000235161.85925.e8","article-title":"Infections associated with orthopedic implants","volume":"19","author":"Trampuz","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0034","doi-asserted-by":"crossref","first-page":"43854","DOI":"10.1038\/srep43854","article-title":"Prevention of Staphylococcus aureus biofilm formation by antibiotics in 96-microtiter well plates and drip flow reactors: critical factors influencing outcomes","volume":"7","author":"Manner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0035","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/AAC.02420-12","article-title":"High activity of fosfomycin and rifampin against methicillin-resistant Staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model","volume":"58","author":"Mihailescu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0036","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nature Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0037","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/eva.12364","article-title":"Long\u2010term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa","volume":"9","author":"Torres\u2010Barcel\u00f3","year":"2016","journal-title":"Evol Appl"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0038","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0039","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/jac\/dkq257","article-title":"Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms","volume":"65","author":"Singh","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.006_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/bact.1.1.13980","article-title":"Lysis from without","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T04:12:27Z","timestamp":1571890347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918302656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0924857918302656"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}